NUZEE INC (NUZE)

US67073S3076 - Common Stock

0.7482  -0.04 (-5.04%)

After market: 0.76 +0.01 (+1.58%)

Fundamental Rating

1

NUZE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 92 industry peers in the Food Products industry. NUZE may be in some trouble as it scores bad on both profitability and health. NUZE is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

NUZE had negative earnings in the past year.
In the past year NUZE has reported a negative cash flow from operations.
NUZE had negative earnings in each of the past 5 years.
In the past 5 years NUZE always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of NUZE (-362.54%) is worse than 98.90% of its industry peers.
Industry RankSector Rank
ROA -362.54%
ROE N/A
ROIC N/A
ROA(3y)-144.26%
ROA(5y)-156.18%
ROE(3y)-265.21%
ROE(5y)-249.59%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NUZE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

NUZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
NUZE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NUZE has more shares outstanding
The debt/assets ratio for NUZE is higher compared to a year ago.

2.2 Solvency

NUZE has an Altman-Z score of -49.46. This is a bad value and indicates that NUZE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NUZE (-49.46) is worse than 97.80% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -49.46
ROIC/WACCN/A
WACC8.88%

2.3 Liquidity

NUZE has a Current Ratio of 0.71. This is a bad value and indicates that NUZE is not financially healthy enough and could expect problems in meeting its short term obligations.
NUZE has a worse Current ratio (0.71) than 83.52% of its industry peers.
NUZE has a Quick Ratio of 0.71. This is a bad value and indicates that NUZE is not financially healthy enough and could expect problems in meeting its short term obligations.
NUZE has a Quick ratio of 0.36. This is amonst the worse of the industry: NUZE underperforms 86.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.36

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.25% over the past year.
NUZE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.20%.
Measured over the past years, NUZE shows a quite strong growth in Revenue. The Revenue has been growing by 19.23% on average per year.
EPS 1Y (TTM)36.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)19.2%
Revenue growth 3Y33.74%
Revenue growth 5Y19.23%
Sales Q2Q%-43.61%

3.2 Future

Based on estimates for the next years, NUZE will show a very strong growth in Earnings Per Share. The EPS will grow by 38.62% on average per year.
NUZE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 114.62% yearly.
EPS Next Y71.17%
EPS Next 2Y38.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100%
Revenue Next 2Y114.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

NUZE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NUZE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NUZE's earnings are expected to grow with 38.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.62%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NUZE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NUZEE INC

NASDAQ:NUZE (10/30/2024, 8:23:59 PM)

After market: 0.76 +0.01 (+1.58%)

0.7482

-0.04 (-5.04%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-19 2024-08-19/amc
Earnings (Next)01-15 2025-01-15/amc
Inst Owners1.47%
Inst Owner Change0%
Ins Owners59.6%
Ins Owner Change23.81%
Market Cap6.37M
Analysts82.86
Price Target8.16 (990.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.38%
Min EPS beat(2)-55.51%
Max EPS beat(2)-7.26%
EPS beat(4)0
Avg EPS beat(4)-45.47%
Min EPS beat(4)-73.65%
Max EPS beat(4)-7.26%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-64.04%
Min Revenue beat(2)-77.57%
Max Revenue beat(2)-50.51%
Revenue beat(4)1
Avg Revenue beat(4)-30.91%
Min Revenue beat(4)-77.57%
Max Revenue beat(4)9.62%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.69
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.37
EYN/A
EPS(NY)-0.84
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS0.44
BVpS-0.02
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -362.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-144.26%
ROA(5y)-156.18%
ROE(3y)-265.21%
ROE(5y)-249.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 162.28%
Cap/Sales 7.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.36
Altman-Z -49.46
F-Score3
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)30.88%
Cap/Depr(5y)115.94%
Cap/Sales(3y)4.27%
Cap/Sales(5y)27.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y71.17%
EPS Next 2Y38.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.2%
Revenue growth 3Y33.74%
Revenue growth 5Y19.23%
Sales Q2Q%-43.61%
Revenue Next Year100%
Revenue Next 2Y114.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.86%
OCF growth 3YN/A
OCF growth 5YN/A